Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-IMilano

This publication has 24 references indexed in Scilit:

• Apolipoprotein function in health and disease: insights from natural mutations
  European Journal of Clinical Investigation, 1996
• Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
  Nature, 1993
• Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.
  Proceedings of the National Academy of Sciences, 1992
• Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.
  Journal of Clinical Investigation, 1991
• High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
  Circulation, 1989
• Apolipoprotein A-I containing lipoproteins in coronary artery disease
  Atherosclerosis, 1987
• Apolipoprotein A-IMilano. Correlation between high density lipoprotein subclass distribution and triglyceridemia.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
• Familial associations of lipids and lipoproteins in a highly consanguineous population: The Limone sul Garda study
  Metabolism, 1985
• A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.
  Journal of Clinical Investigation, 1980
• A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
  Journal of Clinical Investigation, 1980